TY - JOUR
T1 - Allosteric modulation of GAB AA receptor subtypes
T2 - Effects on visual recognition and visuospatial working memory in rhesus monkeys
AU - Soto, Paul Levi
AU - Ator, Nancy A.
AU - Rallapalli, Sundari K.
AU - Biawat, Poonam
AU - Clayton, Terry
AU - Cook, James M.
AU - Weed, Michael Riley
N1 - Funding Information:
This work was supported by NIH grants R01-AG-027798 (NAA), R01-MH-046851 (JMC), and institutional funds of the Division of Behavioral Biology, Department of Psychiatry and Behavioral Sciences, The Johns Hopkins University School of Medicine. In the past 3 years, we have received compensation for professional services as follows: Dr Soto’s work has been funded by the NIH and he has received compensation, unrelated to his scientific work, for database/software consulting from the Shands Hospital at the University of Florida. Dr Ator’s work has been funded by the NIH and she has received funding from Helsinn Healthcare to conduct an abuse liability evaluation of an unrelated compound. Dr Ator also has received compensation from Bristol Myers-Squibb and F Hoffman LaRoche for consulting on abuse liability evaluation. Dr Rallapalli and Dr Biawat have received funding from the NIH. Dr Clayton is an employee of Chromatic Technologies. Chromatic Technologies. provided no financial support for these studies and had no scientific involvement. Dr Cook has received funding from NIH. Dr Cook currently holds patents on several of the compounds used in the current study. Dr Weed initiated these NIH-funded studies at Johns Hopkins School of Medicine before becoming an employee of Bristol Myers-Squibb. Upon leaving Johns Hopkins, direction of the studies was under the exclusive control of Drs. Ator and Soto. Bristol Myers-Squibb provided no financial support for these studies and had no scientific involvement.
PY - 2013/10
Y1 - 2013/10
N2 - Non-selective positive allosteric modulators (PAMs) of GABAA receptors (GABAARs) are known to impair anterograde memory. The role of the various GABAAR subtypes in the memory-impairing effects of non-selective GABAAR PAMs has not been fully elucidated. The current study assessed, in rhesus monkeys, effects of modulation of alpha;1, alpha;2/3, and alpha;5GABAARs on visual recognition and spatial working memory using delayed matching-to-sample (DMTS) and self-ordered spatial search (SOSS) procedures, respectively. The DMTS procedure (n=8) involved selecting a previously presented 'sample' image from a set of multiple images presented after a delay. The SOSS procedure (n=6) involved touching a number of boxes without repeats. The non-selective GABAAR PAM triazolam and the α1GABAA preferential PAMS zolpidem and zaleplon reduced accuracy in both procedures, whereas the α5GABAA preferential PAMs SH-053-20F-R-CH3 and SH-053-20F-S-CH3, and the α2/3GABAA preferential PAM TPA023B were without effects on accuracy or trial completion. The low-efficacy α5GABAAR negative allosteric modulator (NAM) PWZ-029 slightly increased only DMTS accuracy, whereas the high-efficacy α5GABAAR NAMs RY-23 and RY-24 did not affect accuracy under either procedure. Finally, the slopes of the accuracy dose-effect curves for triazolam, zolpidem, and zaleplon increased with box number in the SOSS procedure, but were equivalent across DMTS delays. The present results suggest that (1) a1GABAARs, compared with α2/3 and α5GABAARs, are primarily involved in the impairment, by non-selective GABAAR PAMs, of visual recognition and visuospatial working memory in nonhuman primates; and (2) relative cognitive impairment produced by positive modulation of GABAARs increases with number of locations to be remembered, but not with the delay for remembering.
AB - Non-selective positive allosteric modulators (PAMs) of GABAA receptors (GABAARs) are known to impair anterograde memory. The role of the various GABAAR subtypes in the memory-impairing effects of non-selective GABAAR PAMs has not been fully elucidated. The current study assessed, in rhesus monkeys, effects of modulation of alpha;1, alpha;2/3, and alpha;5GABAARs on visual recognition and spatial working memory using delayed matching-to-sample (DMTS) and self-ordered spatial search (SOSS) procedures, respectively. The DMTS procedure (n=8) involved selecting a previously presented 'sample' image from a set of multiple images presented after a delay. The SOSS procedure (n=6) involved touching a number of boxes without repeats. The non-selective GABAAR PAM triazolam and the α1GABAA preferential PAMS zolpidem and zaleplon reduced accuracy in both procedures, whereas the α5GABAA preferential PAMs SH-053-20F-R-CH3 and SH-053-20F-S-CH3, and the α2/3GABAA preferential PAM TPA023B were without effects on accuracy or trial completion. The low-efficacy α5GABAAR negative allosteric modulator (NAM) PWZ-029 slightly increased only DMTS accuracy, whereas the high-efficacy α5GABAAR NAMs RY-23 and RY-24 did not affect accuracy under either procedure. Finally, the slopes of the accuracy dose-effect curves for triazolam, zolpidem, and zaleplon increased with box number in the SOSS procedure, but were equivalent across DMTS delays. The present results suggest that (1) a1GABAARs, compared with α2/3 and α5GABAARs, are primarily involved in the impairment, by non-selective GABAAR PAMs, of visual recognition and visuospatial working memory in nonhuman primates; and (2) relative cognitive impairment produced by positive modulation of GABAARs increases with number of locations to be remembered, but not with the delay for remembering.
KW - Benzodiazepine
KW - Cognition
KW - Delayed-matching-to-sample
KW - GABA receptor
KW - Rhesus monkey
KW - Self-ordered spatial search
UR - http://www.scopus.com/inward/record.url?scp=84884287810&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84884287810&partnerID=8YFLogxK
U2 - 10.1038/npp.2013.137
DO - 10.1038/npp.2013.137
M3 - Article
C2 - 23722241
AN - SCOPUS:84884287810
SN - 0893-133X
VL - 38
SP - 2315
EP - 2325
JO - Neuropsychopharmacology
JF - Neuropsychopharmacology
IS - 11
ER -